Market By Device Type, Therapeutic Area, Display Technologies, End-user And Geography | Forecast 2019-2027
Triton Market Research estimates that the European biopsy device market is expected to grow at a CAGR of 6.66% in terms of revenue for the forecast years of 2019-2027.
Countries covered in the European biopsy device market are:
• Germany
• The United Kingdom
• Italy
• Spain
• Russia
• France
• Rest of Europe
The region has a fast-growing elderly population, giving rise to a large number of age-related chronic diseases such as skin disorders, kidney diseases, and cancer. These diseases require quick diagnosis using several types of tests, including biopsies. The usage of healthcare services in Europe is high among the elderly individuals due to their susceptibility to diseases and infection. The trend analysis in the region points out that the per capita health expenditure on healthcare is higher among elderly people as compared to people of other ages.
Porter’s five force analysis, market definitions, insights, attractiveness index, market drivers, restraint, challenges and opportunities have been discussed in detail by Triton in this report.
The European region holds the second largest market share of the global biopsy device market. Germany is a leading country in providing biopsy devices in this region. The opening of more healthcare centers and programs pertaining to the awareness of chronic diseases and huge investments in the R&D for developing cost-effective devices by leading manufacturers that can be marketed in developing countries where the chronic cancer patient proportion is high are going to boost the biopsy device market, especially for the needle-based biopsy instrument segment during the forecast years. However, stringent government rules for medical reimbursement, lack of trained professionals and infection risks associated with breast cancer biopsy methods are hampering the growth of European biopsy market.
1. EUROPEAN
BIOPSY DEVICE MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCE OUTLOOK
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTES
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. THREAT
OF RIVALRY
2.3. VENDOR
SCORECARD
2.4. MARKET
ATTRACTIVENESS MATRIX
2.5. KEY
INSIGHTS
2.6. REGULATIONS
OUTLOOK
2.6.1. REGULATION
OF BIOPSY DEVICES IN THE EUROPEAN UNION
2.7. PATENTS
OUTLOOK
2.8. MARKET
DRIVERS
2.8.1. PREVALENCE
OF CHRONIC DISEASES ON THE RISE
2.8.2. GROWING
PUBLIC KNOWLEDGE OF DISEASE TRANSMISSION
2.8.3. INCREASING
DIAGNOSTIC CENTERS
2.9. RESTRAINTS
2.9.1. DEARTH
OF SKILLED PROFESSIONALS
2.9.2. REIMBURSEMENT
ISSUES
2.10.
OPPORTUNITIES
2.10.1.
INCREASING INCIDENCE OF LIVER
DISEASES
2.11.
MARKET CHALLENGES
2.11.1.
LIMITED TECHNICAL SKILLS
2.11.2.
HIGH COST OF BIOPSY TECHNIQUES
3. BIOPSY
DEVICE MARKET OUTLOOK - BY DEVICE TYPE
3.1. BREAST
BIOPSY
3.1.1. VACUUM-ASSISTED
CORE BIOPSY (VAB)
3.1.2. CORE
NEEDLE BIOPSY (CNB)
3.1.3. FINE
NEEDLE BIOPSY
3.2. GASTROINTESTINAL
(GI) BIOPSY
3.3. SOFT
TISSUE BIOPSY NEEDLES
3.4. BRONCHIAL BIOPSY
3.5. GYNECOLOGICAL BIOPSY DEVICE
3.6. ROBOTIC
GUIDANCE SYSTEM
3.7. OTHER
DEVICES
4. BIOPSY
DEVICE MARKET OUTLOOK - BY THERAPEUTIC
AREA
4.1. BREAST
BIOPSY
4.2. GI
BIOPSY
4.3. PROSTATE
BIOPSY
4.4. LIVER
BIOPSY
4.5. LUNG
BIOPSY
4.6. KIDNEY
BIOPSY
4.7. GYNECOLOGICAL BIOPSY
4.8. OTHER
THERAPEUTIC AREA
5. BIOPSY
DEVICE MARKET OUTLOOK - BY DISPLAY TECHNOLOGIES
5.1. MRI-GUIDED
BIOPSY
5.2. STEREOTACTIC-GUIDED BIOPSY
5.3. ULTRASOUND-GUIDED
BIOPSY
5.4. CT-GUIDED
BIOPSY
5.5. OTHER
DISPLAY TECHNOLOGIES
6. BIOPSY
DEVICE MARKET OUTLOOK - BY END-USER
6.1. DIAGNOSIS
CENTER
6.2. HOSPITALS
6.2.1. SPECIALIST
6.2.2. GENERAL
7. BIOPSY
DEVICE MARKET - REGIONAL OUTLOOK
7.1. UNITED
KINGDOM
7.2. FRANCE
7.3. GERMANY
7.4. ITALY
7.5. SPAIN
7.6. RUSSIA
7.7. REST
OF EUROPE
8. COMPANY
PROFILES
8.1. AD-TECH
MEDICAL INSTRUMENT, CORP.
8.2. ARGON
MEDICAL DEVICES, INC.
8.3. B.
BRAUN MELSUNGEN AG
8.4. BECTON,
DICKINSON
8.5. BOSTON
SCIENTIFIC CORPORATION
8.6. CARDINAL
HEALTH, INC.
8.7. C.
R. BARD, INC.
8.8. I.M.S.
INTERNAZIONALE MEDICO SCIENTIFICA SRL
8.9. PLANMECA
OY
8.10.
QIAGEN N.V.
9. METHODOLOGY
& SCOPE
9.1. RESEARCH
SCOPE
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1 EUROPE BIOPSY DEVICE MARKET 2019-2027 ($
MILLION)
TABLE 2 IMPLEMENTATION OF BREAST CANCER
SCREENING PLATFORMS IN EU BY COUNTRY
TABLE 3 EUROPE BIOPSY DEVICE MARKET BY DEVICE
TYPE 2019-2027 ($ MILLION)
TABLE 4 EUROPE BIOPSY DEVICE MARKET IN BREAST
BIOPSY DEVICE BY TYPES 2019-2027 ($ MILLION)
TABLE 5 TYPES OF BREAST BIOPSY AND MAMMOGRAPHY
EQUIPMENT
TABLE 6 TYPES OF BIOPSY CURETTES
TABLE 7 EUROPE BIOPSY DEVICE MARKET BY
THERAPEUTIC AREA 2019-2027 ($ MILLION)
TABLE 8 EUROPE BIOPSY DEVICE MARKET BY DISPLAY
TECHNOLOGIES 2019-2027 ($ MILLION)
TABLE 9 EUROPE BIOPSY DEVICE MARKET BY END-USER
2019-2027 ($ MILLION)
TABLE 10 COMMON AREAS OF BIOPSY
TABLE 11 EUROPE BIOPSY DEVICE MARKET BY COUNTRIES
2019-2027 ($ MILLION)
FIGURE 1 SHARES OF THE EUROPEAN PATENT HOLDER (%)
FIGURE 2 EUROPE BIOPSY DEVICE MARKET IN BREAST
BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 3 EUROPE BREAST BIOPSY DEVICE MARKET IN
VACUUM-ASSISTED CORE BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 4 EUROPE BREAST BIOPSY DEVICE MARKET IN CORE
NEEDLE BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 5 EUROPE BREAST BIOPSY DEVICE MARKET IN FINE
NEEDLE BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 6 EUROPE BIOPSY DEVICE MARKET IN GI BIOPSY
DEVICE 2019-2027 ($ MILLION)
FIGURE 7 EUROPE BIOPSY DEVICE MARKET IN SOFT TISSUE
BIOPSY NEEDLES MARKET 2019-2027 ($ MILLION)
FIGURE 8 EUROPE BIOPSY DEVICE MARKET IN BRONCHIAL
BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 9 EUROPE BIOPSY DEVICE MARKET IN GYNECOLOGICAL
BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 10 EUROPE BIOPSY DEVICE MARKET IN ROBOTIC
GUIDANCE SYSTEM 2019-2027 ($ MILLION)
FIGURE 11 EUROPE BIOPSY DEVICE MARKET IN OTHER BIOPSY
DEVICE 2019-2027 ($ MILLION)
FIGURE 12 EUROPE BIOPSY DEVICE MARKET IN BREAST BIOPSY
THERAPEUTIC AREA 2019-2027 ($ MILLION)
FIGURE 13 EUROPE BIOPSY DEVICE MARKET IN GI BIOPSY
2019-2027 ($ MILLION)
FIGURE 14 EUROPE BIOPSY DEVICE MARKET IN PROSTATE
BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 15 EUROPE BIOPSY DEVICE MARKET IN LIVER BIOPSY
DEVICE 2019-2027 ($ MILLION)
FIGURE 16 EUROPE BIOPSY DEVICE MARKET IN LUNG BIOPSY
DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 17 EUROPE BIOPSY DEVICE MARKET IN KIDNEY BIOPSY
DEVICE 2019-2027 ($ MILLION)
FIGURE 18 EUROPE BIOPSY DEVICE MARKET IN GYNECOLOGICAL
BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 19 EUROPE BIOPSY DEVICE MARKET IN OTHER
THERAPEUTIC AREA 2019-2027 ($ MILLION)
FIGURE 20 EUROPE BIOPSY DEVICE MARKET IN MRI-GUIDED
BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 21 EUROPE BIOPSY DEVICE MARKET IN STEREOTACTIC
BREAST BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 22 EUROPE BIOPSY DEVICE MARKET IN ULTRASOUND-GUIDED
BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 23 EUROPE BIOPSY DEVICE MARKET IN CT-GUIDED
BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 24 EUROPE BIOPSY DEVICE MARKET IN OTHER DISPLAY
TECHNOLOGIES BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 25 EUROPE BIOPSY DEVICE MARKET IN DIAGNOSIS
CENTER 2019-2027 ($ MILLION)
FIGURE 26 EUROPE BIOPSY DEVICE MARKET IN HOSPITAL
2019-2027 ($ MILLION)
FIGURE 27 EUROPE HOSPITAL MARKET IN SPECIALIST HOSPITAL
2019-2027 ($ MILLION)
FIGURE 28 EUROPE HOSPITAL MARKET IN GENERAL HOSPITAL
2019-2027 ($ MILLION)
FIGURE 29 EUROPE BIOPSY DEVICE MARKET 2019-2027 ($
MILLION)
FIGURE 30 UNITED KINGDOM BIOPSY DEVICE MARKET 2019-2027
($ MILLION)
FIGURE 31 FRANCE BIOPSY DEVICE MARKET 2019-2027 ($
MILLION)
FIGURE 32 GERMANY BIOPSY DEVICE MARKET 2019-2027 ($
MILLION)
FIGURE 33 ITALY BIOPSY DEVICE MARKET 2019-2027 ($
MILLION)
FIGURE 34 SPAIN BIOPSY DEVICE MARKET 2019-2027 ($
MILLION)
FIGURE 35 RUSSIA BIOPSY DEVICE MARKET 2019-2027 ($
MILLION)
FIGURE 36 REST OF EUROPE BIOPSY DEVICE MARKET 2019-2027
($ MILLION)